news - International Biopharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

news

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercia...

29 June 2018 news alvogen | announce

Continue Reading →

news

Immunotherapy advances spur new look at cancer vaccines

In an era of cancer immunotherapy, vaccines are getting fresh consideration as a therapeutic approach. Frustrated for years by lackluster results, cancer vaccine res...

29 June 2018 news advances | cancer

Continue Reading →

news

Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors

Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies,...

29 June 2018 news appoints | board

Continue Reading →

news

Lupin, Mylan to commercialize Enbrel Biosimilar

Under the terms of the agreement, Lupin will receive an up-front payment of $15 million. Pharma major Lupin Limited and global pharmaceutical company Mylan have a...

29 June 2018 news Biosimilar | commercialize

Continue Reading →

news

Aptamer Group: UK Biotech Business Raises $2.2M Investment

Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from ...

29 June 2018 news $2.2M | Aptamer

Continue Reading →

news

CellGenix Completed First Step of Facility Expansion to Stay on Top of the Increasing Demands for GMP Cell Culture Reagents

CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first ph...

22 June 2018 news cellgenix | completed

Continue Reading →

news

The International Society for Stem Cell Research brings researchers together in Melbourne

The conference is the world’s largest stem cell meeting and will attract more than 2,500 delegates from 60 countries, delivering around $13 million in economic impact...

22 June 2018 news cell | conference

Continue Reading →

news

Blood vessel-forming cells involved in aggressive brain tumour

Targeting cells involved in blood vessel formation could prevent the growth of the most common type of brain tumour. A type of highly malignant brain tumour contain...

22 June 2018 news aggressive | blood

Continue Reading →

news

WuXi Biologics Initiates Construction of a Integrated ADC Solution Center in China

This $20 million 6,000 square meter facility will be operational in 2019 and provide integrated solutions from concept to commercialization for biologics conjugates...

22 June 2018 news ADC | biologics

Continue Reading →

news

Emulate raises $36M to develop organ-on-chip tech

Boston, Mass.-based Emulate snapped up $36 million in funding from a Series C round led by Founders Fund and including ALS Investment Fund, SciFi VC, GlassWall Sy...

22 June 2018 news $36M | develop

Continue Reading →